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Abstract
Background: Classical scrapie is a naturally occurring transmissible spongiform encephalopathy of sheep and goats
characterized by cellular accumulation of abnormal isoforms of prion protein (PrP
Sc) in the central nervous system
and the follicles of peripheral lymphoid tissues. Previous studies have shown that the whole blood and buffy coat
blood fraction of scrapie infected sheep harbor prion infectivity. Although PrP
Sc has been detected in peripheral
blood mononuclear cells (PBMCs), plasma, and more recently within a subpopulation of B lymphocytes, the
infectivity status of these cells and plasma in sheep remains unknown. Therefore, the objective of this study was to
determine whether circulating PBMCs, B lymphocytes and platelets from classical scrapie infected sheep harbor
prion infectivity using a sheep bioassay.
Results: Serial rectal mucosal biopsy and immunohistochemistry were used to detect preclinical infection in lambs
transfused with whole blood or blood cell fractions from preclinical or clinical scrapie infected sheep. PrP
Sc
immunolabeling was detected in antemortem rectal and postmortem lymphoid tissues from recipient lambs
receiving PBMCs (15/15), CD72
+ B lymphocytes (3/3), CD21
+ B lymphocytes (3/3) or platelet-rich plasma (2/3)
fractions. As expected, whole blood (11/13) and buffy coat (5/5) recipients showed positive PrP
Sc labeling in
lymphoid follicles. However, at 549 days post-transfusion, PrP
Sc was not detected in rectal or other lymphoid
tissues in three sheep receiving platelet-poor plasma fraction.
Conclusions: Prion infectivity was detected in circulating PBMCs, CD72
+ pan B lymphocytes, the CD21
+
subpopulation of B lymphocytes and platelet-rich plasma of classical scrapie infected sheep using a sheep bioassay.
Combining platelets with B lymphocytes might enhance PrP
Sc detection levels in blood samples.
Background
Prion diseases or transmissible spongiform encephalopa-
thies (TSEs) are unique, fatal neurodegenerative disorders
that affect a variety of species including sheep and goats
(scrapie), cattle (bovine spongiform encephalopathy,
BSE), human (Creutzfeldt-Jakob disease, CJD), mink
(transmissible mink encephalopathy, TME), deer, elk and
m o o s e( c h r o n i cw a s t i n gd i s ease, CWD). A characteristic
feature of TSEs is the accumulation of an alternative con-
formational isoform (PrP
Sc) of the host-encoded normal
prion protein (PrP
c) in the central nervous system [1,2].
In classical ovine scrapie, deposition of PrP
Sc in the lym-
phoreticular system precedes accumulation in the central
nervous system [3]. PrP
Sc is readily detected in this
preclinical stage by biopsy of the lymphoid tissue in the
nictitating membrane [4,5] or in the rectoanal mucosa-
associated lymphoid tissue (RAMALT; [6,7]).
The early and persistent presence of PrP
Sc in the lymph
nodes in classical ovine scrapie, human variant CJD
(vCJD), CWD and most rodent scrapie models suggests
that prions are disseminated in the peripheral blood and/
or lymphatics and that peripheral blood might be a suita-
ble target for preclinical diagnostic testing. Prion infectiv-
ity in ovine blood was confirmed by transfusions of whole
blood, buffy coat, red cell concentrates, plasma or platelets
from donor sheep with experimental BSE or classical
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Sc w a sd e t e c t e di nP B M C so f1 0o f1 0
clinical scrapie infected sheep using protein misfolding
cyclic amplification (PMCA) [12] but in only 44 of 80 clin-
ical scrapie infected sheep when using a conventional
enzyme linked immunosorbe n ta s s a y( E L I S A )[ 1 3 ] .A
recent ELISA-based study concluded that PrP
Sc was prin-
cipally associated with a subpopulation of B lymphocytes
in scrapie infected sheep [14]. Although PrP
Sc was
detected in B lymphocytes in 11 of 11 clinical scrapie
infected sheep, B lymphocytes from only three of five scra-
pie infected sheep at the preclinical stage were positive for
PrP
Sc by ELISA. PrP
Sc has also been detected in plasma
samples collected from both preclinical and clinical scrapie
infected sheep but only after combining a novel surround
optical fiber immunoassay (SOFIA) with limited PrP
Sc
amplification by PMCA [15].
Although PrP
Sc has been detected in the blood of scra-
pie-infected sheep by enriching conventional ELISA-based
assay with cellular fractions including PBMCs or B lym-
phocytes, the frequency of such detection was lower dur-
ing the preclinical stage of the disease. Thus, the
objectives of this study were to identify blood fractions of
sheep which harbor relatively high levels of prion infectiv-
ity, including during the preclinical stage of disease. The
present study used a short-observation transfusion model
in the natural host to determine if relatively high infectiv-
ity was present in the total PBMC population, a CD72
+
pan B lymphocyte population, a CD21
+ subpopulation of
B lymphocytes and either platelet-rich or platelet-poor
plasma isolated from the blood of classical scrapie-infected
sheep. In addition, it was also determined if high infectivity
could be demonstrated in both platelet-rich and platelet-
poor plasma during clinical disease. Such demonstrations
should help guide further efforts toward improvement of
ELISA-based scrapie detection sensitivity by pre-assay
enrichment with relevant blood fractions.
Results
Scrapie infectivity associates with blood components
(i) Whole blood transfused recipients develop preclinical
scrapie
Whole blood was collected from three preclinical and
three clinical scrapie infected donor sheep and different
blood volumes were transfused to 13 recipients as shown
in Table 1. Three of four PRNP MARQ/MVRQ recipi-
ents and all four MARQ/MARQ recipients became ante-
mortem RAMALT positive for PrP
Sc between 123 to 235
days post transfusion (dpt) and 222 to 252 dpt, respec-
tively (Table 1). None of these eight animals showed any
signs of scrapie when they were euthanized at 236 to 267
dpt. IHC analysis of postmortem rectal and retropharyn-
geal lymph nodes of all eight animals showed positive
PrP
Sc labeling in lymphoid follicles (Table 2 Figure 1A).
PrP
Sc was undetectable in antemortem and postmortem
rectal tissues and other lymphoid tissues of two MARQ/
TARQ recipients (Tables 1 and 2). PrP
Sc labeling was
also not detected in antemortem rectal biopsies of all
three TARQ/MVRQ animals; however when necropsied
rectal tissues of two animals and retropharyngeal lymph
nodes of all three animals showed positive labeling for
PrP
Sc (Table 2). Clinical signs were not observed in any
of these three recipients and PrP
Sc was undetectable in
brain tissues of all the animals.
(ii) Buffy coat transfused recipients develop preclinical
scrapie
Buffy coat fraction was prepared from one clinical scrapie
infected donor sheep and transfused to five recipients
(Table 1). All three MARQ/MARQ buffy coat recipients
became antemortem RAMALT biopsy positive for PrP
Sc
between 239 to 549 dpt (Table 1 Figure 1B). Postmortem
rectal tissues and retropharyngeal lymph nodes along with
other lymphoid tissues of these three animals showed
positive PrP
Sc labeling in lymphoid follicles (Table 2)
although PrP
Sc was not detected in the brain tissues. Two
of these three animals did not show clinical signs of scra-
pie when they were euthanized at 275 and 306 dpt. Clini-
cal signs of scrapie developed in the remaining animal,
which was euthanized at 1259 dpt. Brain tissue of this ani-
mal (ID 3832) was positive for PrP
Sc by both IHC and WB
assays. One of two remaining buffy coat recipients with
the MARQ/TARQ PRNP genotype became rectal biopsy
positive for PrP
Sc labeling in lymphoid follicles at 757 dpt
while PrP
Sc labeling was not detected from the remaining
other animal at 1095 dpt. There were no clinical signs of
scrapie in either of these two animals when euthanized at
1391 dpt (Table 1). Postmortem rectal tissues and retro-
pharyngeal lymph nodes along with other lymphoid tissues
of the RAMALT positive animal (ID 3819) showed posi-
tive PrP
Sc labeling in lymphoid follicles and the brain tis-
sues by IHC (Table 2). Lymphoid follicles of
retropharyngeal lymph nodes and ileocecal junction of the
other animals (ID 3825) showed positive PrP
Sc labeling
(Table 2).
(iii) Peripheral blood mononuclear cell transfused recipients
develop preclinical scrapie
PBMCs were prepared from five preclinical scrapie
infected donor sheep and transfused to 15 recipients
(Table 1). Antemortem rectal biopsies from four of five
MVRQ/MVRQ recipients (including three CD18
+-labeled
PBMC recipients) became positive for PrP
Sc labeling
between 125 and 182 dpt (Table 1 Figure 1C). There were
no clinical signs of scrapie in any of these animals. All five
were euthanized between 181 and 646 dpt. Rectal tissues,
retropharyngeal lymph nodes and most other lymphoid
tissues of all five animals showed positive PrP
Sc labeling in
lymphoid follicles (Tables 1 and 2). PrP
Sc labeling in brain
tissues was only detected in one animal (ID 4302). Ante-
mortem rectal biopsies of six of nine MARQ/MVRQ
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Page 2 of 11Table 1 Sheep transfused with different blood components from scrapie infected sheep.
Transfusion types Transfusion outcomes
Blood
component
blood volume
(mL)
1
Donor
ID
Clinical
status
Donor
PRNP
Recipient
PRNP
Recipient ID Rectal tissues PrP
Sc detection by
IHC
dpt to first positive
biopsy
dpt at
necropsy
Whole blood 50 3806/
3807
Preclinical MVRQ/
MVRQ
MARQ/MVRQ 4128/4132/
4134
Positive 156-235 267
131 3178 Preclinical MARQ/
MARQ
MARQ/MARQ 3668 Positive 252 261
MARQ/TARQ 3669/3670 Not detected 236-261
135 3187 Clinical MARQ/
MVRQ
TARQ/MVRQ 3613/3622 Positive 185-213
3188 Clinical MARQ/
MVRQ
TARQ/MVRQ 3628 Not detected 213
MARQ/MVRQ 3672 Positive 123 215
119-131 3199 Clinical MARQ/
MARQ
MARQ/MARQ 3665/3666/
3667
Positive 222-252 236-261
Buffy coat 100 3345 Clinical MARQ/
MARQ
MARQ/MARQ 3823/3833 Positive 239-288 275-306
MARQ/MARQ 3832 Positive 549 1259
MARQ/TARQ 3819 Positive 757 1391
MARQ/TARQ 3825 Not detected 1391
PBMCs 50 4073 Preclinical MVRQ/
MVRQ
MVRQ/MVRQ 4302 Positive 182 646
MARQ/MVRQ 4288/4309 Positive 182 646
MARQ/MVRQ 4304/4305 Positive 251
100 3806/
3807
Preclinical MVRQ/
MVRQ
MARQ/MVRQ 4118/4119/
4123
Positive 153-214 306
TARQ/MVRQ 4120 Positive 153 306
116 3774 Preclinical MVRQ/
MVRQ
MVRQ/MVRQ 3824 Positive 175 183
MARQ/MVRQ 3921 Positive 175 183
MARQ/MVRQ 3920 Positive 187
50
@ 4125 Preclinical MVRQ/
MVRQ
MVRQ/MVRQ 4378/4380 Positive 125 181
MVRQ/MVRQ 4379 Positive 181
CD72
+ B cells 50
# 4125 Preclinical MVRQ/
MVRQ
MVRQ/MVRQ 4384/4385/
4386
Positive 125-152 181
CD21
+ B cells 50
& 4125 Preclinical MVRQ/
MVRQ
MVRQ/MVRQ 4381/4383 Positive 125-152 187
MVRQ/MVRQ 4382 Positive 187
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1Table 1 Sheep transfused with different blood components from scrapie infected sheep. (Continued)
Platelet-rich 180 3199 Clinical MARQ/
MARQ
MARQ/MARQ 3606 Positive 218 357
plasma 100 3345 Clinical MARQ/
MARQ
MARQ/MARQ 3820 Positive 288 554
MARQ/MARQ 3821 Not detected 552
Platelet-poor
plasma
100 3345 Clinical MARQ/
MARQ
MARQ/MARQ 3822/3836/
3838
Not detected 549
abbreviations: PBMCs = peripheral blood mononuclear cells; IHC = immunohistochemistry on antemortem and postmortem rectal tissues; PRNP = haplotypes shown include deduced amino acids at codons 112, 136,
154, 171; dpt = days post-transfusion; cells labeled with magnetic beads:
@CD18-labeled PBMCs;
#CD72-labeled B cells (Pan B lymphocytes);
&CD21-labeled CD21
+ B cells (a subpopulation of B lymphocytes), these
cells were labeled with primary and magnetic microbeads coupled secondary antibodies
1Total whole blood volume from which each inoculum was derived per recipient animal.
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1animals showed positive PrP
Sc labeling in lymphoid folli-
cles between 153 and 214 dpt. Rectal tissues collected at
necropsy from two of three previously RAMALT PrP
Sc
undetectable animals remained undetectable for PrP
Sc
labeling in lymphoid follicles (Table 2). Only the retro-
pharyngeal lymph node of one recipient (ID 4305) showed
positive PrP
Sc labeling while most of the other lymphoid
tissues collected at necropsy from all the other eight ani-
mals showed positive PrP
Sc labeling in lymphoid follicles.
Brain tissues of two animals necropsied at 646 dpt showed
positive PrP
Sc labeling while PrP
Sc labeling was not
detected in all the other animals. Antemortem rectal tissue
of the remaining TARQ/MVRQ recipient was positive for
PrP
Sc at 153 dpt. Rectal tissues, retropharyngeal lymph
nodes and several other lymphoid tissues collected at
necropsy from this animal showed positive PrP
Sc labeling
in lymphoid follicles (Table 2). However, PrP
Sc was not
undetected in the brain tissues.
(iv) B lymphocyte recipients develop preclinical scrapie
Since PBMCs from four donor animals were able to cause
scrapie in recipient sheep, another preclinical scrapie
infected sheep was selected as a blood donor to identify
prion infectivity in B lymphocytes. As a control for the
study, three recipients were transfused with CD18-labeled
PBMCs and all the recipients in this group showed posi-
tive PrP
Sc labeling in lymphoid follicles (Table 1). Since
MVRQ/MVRQ animals became PrP
Sc positive more
quickly than other genotypes, six lambs with this genotype
were selected for the B lymphocyte transfusion experi-
ment. CD72
+ B lymphocytes and CD21
+ B lymphocytes
were separated from PBMCs using a magnetic labeling
procedure with 95% purity as assessed by flow cytometry
(data not shown). IHC examination of antemortem rectal
biopsies collected from all three CD72
+ (Figure 1D) and
two of three CD21
+ (Figure 1E) B lymphocyte recipients
showed positive PrP
Sc labeling between 125 and 152 dpt
(Table 1). Rectal as well as all the other lymphoid tissues
collected from both types of B lymphocyte recipients at
necropsy showed positive PrP
Sc labeling in lymphoid folli-
cles (Table 2). However, PrP
Sc was not detected from any
of the brain tissues of all six animals.
(v) Platelet-rich plasma recipients develop preclinical scrapie
Platelet-rich and platelet-poor plasma was prepared
from two clinical scrapie infected donor sheep and
transfused to six recipients. Three MARQ/MARQ lambs
were transfused with platelet-rich plasma prepared from
two clinical scrapie donors (Table 1). Antemortem rectal
biopsies of two of three recipients showed positive PrP
Sc
labeling between 218 and 288 dpt (Figure 1F). The three
animals did not show any clinical signs of scrapie when
they were euthanized at 357 or 554 dpt. PrP
Sc was
detected in retropharyngeal lymph nodes and all the
other lymphoid tissues examined in the two rectal
biopsy positive animals, but PrP
Sc was not detected in
the same tissues in the previously biopsy negative ani-
mal (Table 2). In addition, PrP
Sc remained undetectable
in brain tissues from these animals. PrP
Sc was not
detected in the tissues from the three recipients of plate-
let-poor plasma when euthanized at 549 dpt (Table 1
Table 2 Figure 1G).
Table 2 Summary of PrP
Sc detection in multiple tissues from sheep transfused with different blood components from
scrapie infected sheep
Blood components Recipient PrP
Sc detection by IHC *Scrapie
PRNP Antemortem Postmortem positive (%)
Rectal tissues Rectal
tissues
Other lymphoid tissues
Whole blood MARQ/MARQ 4/4 4/4 4/4 100
MARQ/MVRQ 3/4 4/4 4/4 100
MARQ/TARQ 0/2 0/2 0/2 0
TARQ/MVRQ 0/3 2/3 3/3 100
Buffy coat MARQ/MARQ 3/3 3/3 3/3 100
MARQ/TARQ 1/2 1/2 2/2 100
PBMCs MVRQ/MVRQ 4/5 5/5 5/5 100
MARQ/MVRQ 6/9 7/9 9/9 100
TARQ/MVRQ 1/1 1/1 1/1 100
CD72
+ B lymphocytes MVRQ/MVRQ 3/3 3/3 3/3 100
CD21
+ B lymphocytes MVRQ/MVRQ 2/3 3/3 3/3 100
Platelet-rich plasma MARQ/MARQ 2/3 2/3 2/3 67
Platelet-poor plasma MARQ/MARQ 0/3 0/3 0/3 0
Other lymphoid tissues = retropharyngeal lymph nodes, palatine tonsil, spleen, ileo-cecal junction, ileo-cecal lymph node or mesenteric lymph nodes; IHC =
immunohistochemistry; *Scrapie positive PrP
Sc was detected in one or more lymphoid tissues at necropsy
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Removal of exogenous and endogenous prion infectivity
from red blood cell preparations of scrapie-infected ham-
ster blood by leukoreduction filters resulted in significant
reduction of scrapie infection in hamsters following
transfusion [16]. Leukodepletion significantly reduced the
risk of vCJD transmission in human following blood
transfusion recipients as well [17,18]. However, a recent
study by McCutcheon et al., (2011) revealed that leucore-
duction did not prevent the BSE transmission to sheep
following a single blood transfusion [11]. Detection of
PrP
Sc labeling in the lymphoid tissues and development
of clinical scrapie in whole blood and buffy coat transfu-
sion recipients in this study as well as in previous studies
[8-10] confirmed that prion infectivity is associated with
blood from classical scrapie infected sheep. Although
previous sheep blood transfusion studies used a relatively
large volume of whole blood (400 - 500 mL), volumes of
50 - 135 mL whole blood from scrapie infected sheep
were sufficient to transmit scrapie infection to the most
recipients in this study. It is difficult to avoid the loss of
PBMCs during density-gradient cell separation and
MACS-based cell enrichment procedures (CD72
+ and/or
CD21
+ B lymphocytes) due to the multiple washing steps
involved and the inherent limitation to the cell-binding
capacity of the columns. Therefore, it is possible that
even much lower volumes of scrapie infected sheep
blood might be sufficient to cause infection in sheep.
Demonstration of prion infectivity in much smaller
volumes of blood may be helpful in development of con-
ventional blood-based diagnostic testing for scrapie in
sheep.
We used standard IHC detection of PrP
Sc in tissues as
a surrogate marker for transmission of infectivity to
Figure 1 Immunolabeling of PrP
Sc in the rectoanal mucosa-associated lymphoid tissues of recipient sheep transfused with different
blood components. PrP
Sc immunolabeling (dark red) was visible in the RAMALT follicles of recipient sheep receiving either whole blood (A),
buffy coat (B), PBMCs (C), CD72
+ B lymphocytes (D), CD21
+ B lymphocytes (E) or platelet-rich plasma (F) fractions but not after receiving a
platelet-poor plasma (G) fraction when labeled with anti-prion mAbs. PrP
Sc immunolabeling was not observed in RAMALT follicles of scrapie
negative (H) sheep or when using an isotype-matched control mAb (I; same tissue block shown in F). Scale bar = 50 μm.
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Page 6 of 11preclinical recipient sheep. Analysis of antemortem and
postmortem lymphoid tissues in sheep receiving transfu-
sion with the PBMC fractions were confirmed positive
for PrP
Sc immunolabeling indicating that prion infectivity
is associated with PBMC fraction of sheep blood. Pre-
vious studies showed PrP
Sc was detected from PBMCs
[12,13] and a subpopulation of B lymphocytes [14]. CD72
has been identified as a pan B lymphocyte marker in
sheep [19] and also in mice [20]. Approximately 50% of
adult sheep B lymphocytes are positive for CD21 [19]. A
significant proportion of peripheral lymphocytes recircu-
late continuously between the blood, the lymph and the
tissues. The lymph nodes are the major site of exchange
for recirculating lymphocytes between the blood and the
lymph. The migration competent or recirculating B lym-
phocytes readily migrate into the lymphatic recirculation
pathway due to the cell surface expression of CD21 and
CD62L or L-selectin [19]. Therefore, we used anti-CD72
and anti-CD21 mAbs to isolate pan B lymphocytes and
recirculating B lymphocytes from the PBMCs fraction,
respectively. Transfusion of CD72
+ B lymphocytes or
CD21
+ B lymphocytes from scrapie infected sheep
resulted in PrP
Sc detection in lymphoid tissues of recipi-
ents. These results are consistent with PrP
Sc being
detected in MHC class II DQ
+,s I g M
+, CD11b
+, CD11c
+
and CD21
+/- B lymphocytes in sheep [14], and CD72
+ B
lymphocytes harboring infectious CWD prions in white-
tailed deer [21].
The present study utilized a short observation period in
the natural host as a model biased for quick detection of
blood fractions having relatively high prion levels. The
platelet-poor plasma fraction from scrapie infected sheep
did not contain adequate levels of prion infectivity for
detection in this model. Two of the three MARQ/MARQ
lambs transfused with platelet rich plasma were positive
by rectal biopsy 218 and 288 post-transfusion, approxi-
mately the same interval seen in MARQ/MARQ lambs
transfused with whole blood (222-252 dpt, n = 4) or
buffy coat cells (239-288 days, n = 2). CWD and BSE
infectivity were associated with platelets or platelet-rich
plasma pellets in white-tailed deer [21] and sheep [11],
respectively. However, hamsters inoculated with platelets
from scrapie infected hamsters did not develop scrapie
[22]. The possibility exists that rodent models and rumi-
nants have slightly different cells that contain infectivity
or the processing of platelets could affect scrapie infectiv-
ity. Other studies have suggested that there is cell-free
PrP
Sc in sheep plasma [15,22]. Passage of radioactively
labeled, highly purified murine PrP
Sc through the mouse
blood-brain barrier [23] and detection of PrP
Sc in sheep
circumventricular organs that lack a blood-brain barrier
[24] suggest the possibility of cell-free PrP
Sc in the blood.
Detection of PrP
Sc by PMCA in hamster plasma samples
devoid of platelets suggests the possibility of cell-free
PrP
Sc in hamster plasma [25,26]. Similarly, vCJD infectiv-
ity in plasma components has been reported from human
donors suggesting cell-free plasma can also carry infec-
tious vCJD prions [27,28]. Given the similarity in patho-
genesis between BSE and scrapie infection in sheep, one
would expect similar outcome from both forms. How-
ever, a recent study by McCutcheon et al., (2011) with
BSE-infected sheep revealed that platelet-poor plasma
supernatant can also efficiently transmit prion infectivity
to recipient lambs following a single blood transfusion
[11]. The detection of preclinical scrapie in recipient
lambs took 594 to 1089 dpt. The lack of PrP
Sc detection
in lymphoid tissues of platelet-poor plasma recipients in
our study could have been due to a lower prion titer in
platelet-poor plasma samples and/or necropsy of animals
at 550 dpt. Poisson distribution of particles in solution
indicates a far greater number of recipient animals per
group would have been necessary to distinguish sample
fraction “titers”. In contrast to sheep, hamster and
human findings, recent studies in white-tailed deer and
cervidized transgenic mouse revealed that CWD infectiv-
ity was not associated with platelet-poor plasma, but with
platelets [21]. Although the presence of PrP
Sc in ham-
sters’ plasma fraction is confirmed, prion infectivity in
that fraction has not yet been reported.
Our previous study demonstrated that one nonsynon-
ymous allele (T112) was associated with prolonged survi-
val in MARQ/TARQ scrapie-exposed sheep compared to
MARQ/MARQ sheep [29]. Although the focus of this
study was to identify which blood components carry
prion infectivity, four MARQ/TARQ and four TARQ/
MVRQ animals were included to assess whether T112
polymorphism might delay PrP
Sc d e t e c t i o ni nR A M A L T
follicles following infection by transfusion. Lack of PrP
Sc
labeling in RAMALT follicles of six of eight recipients
confirms that T112 polymorphism delayed prion accu-
mulation in sheep rectal lymphoid tissues. Although the
number of animals used in this study was limited, the
delay in PrP
Sc accumulation in RAMALT particularly in
MARQ/TARQ animals needs to be considered when
scrapie diagnosis is determined.
Conclusions
This study demonstrated that prion infectivity is asso-
ciated with B lymphocytes and platelet-rich plasma of
sheep with classical scrapie. Enrichment of platelets as
well as B lymphocytes should enhance assay detection
sensitivity for scrapie.
Methods
Blood donor and recipient sheep
All experimental protocols used in this study were
approved by the Institutional Animal Care and Use Com-
mittee (IACUC) at Washington State University before
Dassanayake et al. BMC Veterinary Research 2011, 7:75
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Page 7 of 11onset of the study. All donor animals were naturally
infected with scrapie and housed at a USDA ARS quaran-
tine facility. Six preclinical (1 MARQ/MARQ, 5 MVRQ/
MVRQ) and four clinical (2 MARQ/MARQ, 2 MARQ/
MVRQ) scrapie animals were selected as blood donors.
Eight of the donor sheep were born and raised in a
persistently scrapie-infected flock at the USDA animal
research unit at Pullman, WA and developed either
preclinical or clinical scrapie. Donor 3774 was received
from a privately owned scrapie-infected flock while
4125 was brought from a clean flock and developed pre-
clinical scrapie at our research facility. These animals
were mixed breeds of white face or black face sheep. The
ages of the donor animals were in the range of 14 to
36 months at the time of blood collection. PrP
Sc was
detected by IHC in brain and lymphoid tissues collected
at necropsy from all the donor sheep (Figure 2). To
further confirm PrP
Sc detection by IHC, two preclinical
and four clinical donor brain tissues were selected for
western blot study. Three PK-resistant bands corre-
sponding to di-, mono- and un-glycosylated isoforms of
PrP
Sc were detected with anti-prion mAb F99/97.6.1 [5]
(data not shown). Serum samples collected from donor
and recipient animals were negative for ovine progressive
pneumonia virus antibody using a cELISA (data not
shown). The PRNP genotypes of donor and recipient
sheep were determined by sequencing of open reading
frame of the PRNP gene [30]. Genotypes are shown by
the deduced amino acid residues at positions 112, 136,
154 and 171 respectively. Sheep with PRNP genotypes
encoding methionine (M) or threonine (T) at codon 112,
alanine (A) or valine (V) at 136, arginine (R) at 154 and
glutamine (Q) at 171 were selected for this study. PRNP
genotypes and scrapie status of donor and recipient
sheep are shown in Table 1. At approximately four-
months of age, recipient lambs received from a scrapie
negative flock at our facility, USDA ARS sheep experi-
ment station at Dubois, ID, University of Idaho, Moscow,
ID or privately owned farms were transferred to isolation
buildings or outdoor pens with no direct contact with
scrapie infected sheep. These lambs were mixed breed of
white face or black face sheep.
Isolation of blood components and transfusion
All the donor animals were physically restrained during
the blood collection and no chemical sedatives were used.
During blood transfusion, lambs were also physically
restrained and blood or blood components were adminis-
tered through jugular vein. Jugular venous blood samples
from six preclinical and four clinical scrapie positive donor
sheep were collected into evacuated containers (Baxter
Healthcare Co., Deerfield, IL; 150 - 500 mL capacity) con-
taining acid citrate dextrose as an anticoagulant. The
volume of whole blood and the blood fractions derived
Figure 2 Immunolabeling of PrP
Sc in the brains and retropharyngeal lymph nodes of scrapie infected donor sheep.W i d e s p r e a d
immunolabeling of PrP
Sc (dark red) deposits was observed in the brains (A, B) and retropharyngeal lymph node follicles (D, E) of preclinical and
clinical scrapie infected donor animals after labeling tissues with anti-prion mAbs, respectively. No PrP
Sc immunolabeling was observed in the
brain from a sheep without scrapie labeled with the same anti-prion mAbs (C). Immunolabeling of retropharyngeal lymph nodes section from
the same scrapie donor sheep (E) block labeled with isotype-matched control mAb (F) shows no non-specific labeling. Scale bars = 50 μm.
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sion are shown in Table 1. Each animal received the indi-
cated volume of blood or the cells isolated from the
indicated volume of whole blood. Plasma from whole
blood was initially separated by centrifugation (380 × g for
30 min) and was further centrifuged (1500 × g twice for
15 min each) to prepare platelet-poor plasma. Buffy coat
cells collected from centrifuged blood samples were
washed twice with phosphate-buffered saline (PBS, Cellgro
Inc., Manassas, VA) containing 2 mM EDTA (PBS-EDTA,
pH 7.2). Erythrocytes were removed by a short incubation
of the buffy coat in erythrocyte lysis solution (Qiagen Inc.,
Valence, CA) followed by two washes in PBS-EDTA.
Thereafter, each buffy coat pellet was re-suspended in 10
mL normal saline and transfused into recipient lambs
through the jugular vein. To separate peripheral blood
mononuclear cells (PBMCs) from polymorphonuclear
cells, buffy coat suspensions were carefully layered onto
Accu-Paque™ (Accurate Chemicals, Westbury, NY) den-
sity gradient solution (density - 1.088 g/mL; osmolarity -
350 mOsm) and centrifuged (380 × g for 30 min). PBMCs
were collected from the plasma-Accu-Paque interface and
any remaining erythrocytes were removed by incubation
with erythrocyte lysis solution. PBMCs were washed twice
with PBS-EDTA, resuspended in 10 mL normal saline and
transfused into recipient lambs.
PBMCs collected from 450 mL of blood from donor
sheep 4125 (Table 1) were further processed to enrich for
B lymphocytes using a magnetic cell sorting system
(MACS; Miltenyi Biotech, Auburn, CA). Briefly, PBMCs
were resuspended in Hanks-balanced salt solution (HBSS;
Invitrogen, Carlsbad, CA) containing 2 mM EDTA and 2%
fetal bovine serum (FBS) and divided into three tubes.
Each tube was then incubated with either anti-CD72 (2-
104, IgM, kindly provided by Dr. Young), anti-CD21
(BAQ15A, IgM; VMRD Inc., Pullman WA) or anti-CD18
(HUH82A, IgG2a; VMRD) murine monoclonal antibodies
(mAbs) for 30 min on ice. Cells in each tube were washed
twice in HBSS and then incubated with rat anti-mouse
IgM- or IgG2a-b- coupled magnetic microbeads (Miltenyi)
for 15 min on ice. To determine the enrichment purity by
flow cytometry, mAb-labeled cells were incubated with
either FITC-labeled goat anti-mouse IgM or IgG2a for
5m i n .C D 7 2
+ and CD21
+ labeled B lymphocytes were
separated from other PBMCs by passing through LS
MACS columns (Miltenyi), washed, and resuspended in
10 mL normal saline. To assess whether magnetic labeling
of cells interferes with cell circulation and prion develop-
ment, PBMCs were labeled with anti-CD18, anti-IgG2a-b
and FITC-IgG2a mAbs. These CD18-labeled PBMCs were
not subjected to MACS columns enrichment and were
used as a positive control for the study. Approximately 5 ×
10
7 CD18-labeled PBMCs, 2 × 10
7 CD72
+ B cells and 7 ×
10
6 CD21
+ B cells were isolated from the initial 50 mL of
whole blood and transfused into lambs. Lambs (three ani-
mals per group) received CD72
+ B cells, CD21
+ B cells or
CD18-labeled PBMCs. Whole blood, platelet and plasma
recipients were held in the quarantine facility in pens with
no access to other infected sheep or goats.
Scrapie diagnosis by immunohistochemistry and western
blot assays
Antemortem diagnosis of scrapie was made by biopsy of
the rectal mucosa and detection of PrP
Sc by IHC. Samples
were collected from each recipient lamb as follows:
MVRQ/MVRQ recipients: first biopsy at four months and
monthly thereafter; MARQ/MVRQ or TARQ/MVRQ
recipients: first biopsy at six months and one to two
months thereafter; MARQ/MARQ or MARQ/TARQ reci-
pients: first biopsy at eight months and nine, 15, 18, 25
and 36 months thereafter. Animals were euthanized by
intravenous administration of a pentobarbital-based eutha-
nasia solution (Vortech, Dearborn, MI) when most of the
recipients in the same group became rectal biopsy positive
for PrP
Sc (Table 1). Antemortem and postmortem rectal
tissues, postmortem lymphoid tissues (retropharyngeal
lymph nodes, palatine tonsils, spleen, ileo-cecal junction,
ileo-cecal lymph nodes and mesenteric lymph nodes) and
brains were fixed in formalin and processed according to
standard procedures. Three μm sections mounted on trea-
ted glass slides (Superfrost
®/Plus, Fisher Scientific, Pitts-
burg, PA) were immunolabeled with a combination of
mAbs F89/160.1.5 [31] and F99/97.6.1 [5] using an auto-
mated immunolabeler (Benchmark, Ventana Medical Sys-
tems, Tucson, AZ), and counterstained with hematoxylin
as previously described [32]. Positive and negative ovine
lymphoid and brain tissues were used as run control sam-
ples. Immunolabeling intensity of the positive control tis-
sue was equivalent for all runs and no labeling was
observed in negative control tissues or in positive control
tissues for which an isotype-matched mAb was substituted
for the anti-PrP mAbs. Samples were considered positive
for PrP
Sc if coarse dark red deposits were detected in the
lymphoid follicles or in the dorsal motor nucleus of the
vagus nerve at the level of obex by using bright-field
microscopy. Photomicrographs were taken with an Olym-
pus BX40 microscope coupled with an Olympus Q-Color3
camera. Axiovision software was used for scaling and
Adobe Photoshop Elements 5.0 for formatting. Brain tis-
sue samples from two preclinical and all four clinical
donor sheep collected at necropsy were selected for
further analysis for PrP
Sc by western blot assays as
described previously [32-34]. Briefly, proteinase K (50 μg/
mL final concentration) was directly added into 100 μl
10% (w/v) brain homogenates and incubated at 50°C for 1
h. Ten microliters of homogenates were mixed with SDS-
PAGE sample loading buffer and loaded onto a 12% Nu-
PAGE Bis-Tris gel (Invitrogen). After electrophoresis,
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Page 9 of 11proteins were transferred onto PVDF membranes, blocked
with commercial casein blocker (Pierce, Rockford, IL) and
incubated with primary mAb F99/97.6.1 followed by incu-
bation with a horseradish peroxidase conjugated goat anti-
mouse secondary Ab (SouthernBiotech, Birmingham, AL).
Bound antibody was detected by chemiluminescence
(Amersham ECL™, GE healthcare, Piscataway, NJ). Mem-
branes were exposed to radiographic films (KodakBioMax
Chemiluminescence Films) and evaluated for di-, mono-
and un-glycosylated PrP
Sc banding patterns. Positive and
negative sheep brain homogenates and isotype-matched
mAbs were used as controls for the assay.
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